BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 36134203)

  • 1. Preparation of Betulinic Acid Galactosylated Chitosan Nanoparticles and Their Effect on Liver Fibrosis.
    Wu ZC; Liu XY; Liu JY; Piao JS; Piao MG
    Int J Nanomedicine; 2022; 17():4195-4210. PubMed ID: 36134203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of long-circulating nanoparticles loaded with betulinic acid for improved anti-tumor efficacy.
    Saneja A; Kumar R; Singh A; Dhar Dubey R; Mintoo MJ; Singh G; Mondhe DM; Panda AK; Gupta PN
    Int J Pharm; 2017 Oct; 531(1):153-166. PubMed ID: 28823888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery.
    Wang Q; Zhang L; Hu W; Hu ZH; Bei YY; Xu JY; Wang WJ; Zhang XN; Zhang Q
    Nanomedicine; 2010 Apr; 6(2):371-81. PubMed ID: 19699319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apocynin-loaded PLGA nanomedicine tailored with galactosylated chitosan intrigue asialoglycoprotein receptor in hepatic carcinoma: Prospective targeted therapy.
    Anter HM; Aman RM; Othman DIA; Elamin KM; Hashim IIA; Meshali MM
    Int J Pharm; 2023 Jan; 631():122536. PubMed ID: 36572262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of Biotin-Modified Galactosylated Chitosan Nanoparticles and Their Characteristics in Vitro and in Vivo.
    Cheng M; Ma D; Zhi K; Liu B; Zhu W
    Cell Physiol Biochem; 2018; 50(2):569-584. PubMed ID: 30308481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis between four model nanoformulations of amphotericin B-chitosan, amphotericin B-dendrimer, betulinic acid-chitosan and betulinic acid-dendrimer for treatment of
    Zadeh Mehrizi T; Khamesipour A; Shafiee Ardestani M; Ebrahimi Shahmabadi H; Haji Molla Hoseini M; Mosaffa N; Ramezani A
    Int J Nanomedicine; 2019; 14():7593-7607. PubMed ID: 31802863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Betulinic acid prevents liver fibrosis by binding Lck and suppressing Lck in HSC activation and proliferation.
    Zhao H; Wu L; Zhang Y; Feng S; Ding Y; Deng X; Feng R; Li J; Ma T; Huang C
    J Ethnopharmacol; 2022 Oct; 296():115459. PubMed ID: 35714879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Betulinic acid self-assembled nanoparticles for effective treatment of glioblastoma.
    Li Y; Wang Y; Gao L; Tan Y; Cai J; Ye Z; Chen AT; Xu Y; Zhao L; Tong S; Sun Q; Liu B; Zhang S; Tian D; Deng G; Zhou J; Chen Q
    J Nanobiotechnology; 2022 Jan; 20(1):39. PubMed ID: 35062946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galactosylated chitosan nanoparticles for hepatocyte-targeted delivery of oridonin.
    Zheng D; Duan C; Zhang D; Jia L; Liu G; Liu Y; Wang F; Li C; Guo H; Zhang Q
    Int J Pharm; 2012 Oct; 436(1-2):379-86. PubMed ID: 22732673
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Sun R; Fang L; Lv X; Fang J; Wang Y; Chen D; Wang L; Chen J; Qi Y; Tang Z; Zhang J; Tian Y
    Drug Deliv; 2021 Dec; 28(1):2071-2084. PubMed ID: 34595970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally targeted galactosylated chitosan poly(lactic-co-glycolic acid) nanoparticles loaded with TNF-ɑ siRNA provide a novel strategy for the experimental treatment of ulcerative colitis.
    Huang Y; Guo J; Gui S
    Eur J Pharm Sci; 2018 Dec; 125():232-243. PubMed ID: 30315858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Galactosylated chitosan triptolide nanoparticles for overcoming hepatocellular carcinoma: Enhanced therapeutic efficacy, low toxicity, and validated network regulatory mechanisms.
    Zhang YQ; Shen Y; Liao MM; Mao X; Mi GJ; You C; Guo QY; Li WJ; Wang XY; Lin N; Webster TJ
    Nanomedicine; 2019 Jan; 15(1):86-97. PubMed ID: 30244085
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of hepatic stellate cell activation using JQ1- and atorvastatin-loaded chitosan nanoparticles as a promising approach in therapy of liver fibrosis.
    Hassan R; Tammam SN; Safy SE; Abdel-Halim M; Asimakopoulou A; Weiskirchen R; Mansour S
    Eur J Pharm Biopharm; 2019 Jan; 134():96-106. PubMed ID: 30471341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collagenase loaded chitosan nanoparticles for digestion of the collagenous scar in liver fibrosis: The effect of chitosan intrinsic collagen binding on the success of targeting.
    El-Safy S; Tammam SN; Abdel-Halim M; Ali ME; Youshia J; Shetab Boushehri MA; Lamprecht A; Mansour S
    Eur J Pharm Biopharm; 2020 Mar; 148():54-66. PubMed ID: 31945489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and Cytotoxicity of Polyprenol Lipid and Vitamin E-TPGS Hybrid Nanoparticles for Betulinic Acid and Low-Substituted Hydroxyl Fullerenol in MHCC97H and L02 Cells.
    Tao R; Wang C; Lu Y; Zhang C; Zhou H; Chen H; Li W
    Int J Nanomedicine; 2020; 15():2733-2749. PubMed ID: 32368052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin-loaded galactosylated BSA nanoparticles as targeted drug delivery carriers inhibit hepatocellular carcinoma cell proliferation and migration.
    Huang Y; Hu L; Huang S; Xu W; Wan J; Wang D; Zheng G; Xia Z
    Int J Nanomedicine; 2018; 13():8309-8323. PubMed ID: 30584302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fabrication, characterization, and lipid-lowering effects of naringenin-zein-sodium caseinate-galactosylated chitosan nanoparticles.
    Zhang H; Liu R; Wang J; Cui SW; Wang S; Wang B; Zhang N; Yang X; Li J; Wang H
    Int J Biol Macromol; 2023 Mar; 230():123150. PubMed ID: 36621730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting.
    Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q
    Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The liver-targeting study of the N-galactosylated chitosan in vivo and in vitro.
    Liang M; Zheng X; Tu L; Ma Z; Wang Z; Yan D; Shen Z
    Artif Cells Nanomed Biotechnol; 2014 Dec; 42(6):423-8. PubMed ID: 24066968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-loaded galactose-conjugated poly(d,l-lactide-co-glycolide) nanoparticles as hepatocyte-targeting drug carrier.
    Margarida Cardoso M; Peça IN; Raposo CD; Petrova KT; Teresa Barros M; Gardner R; Bicho A
    J Microencapsul; 2016 Jun; 33(4):315-22. PubMed ID: 27189857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.